Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis. [Phase 3]
A Phase III clinical study evaluating QY201 Tablet in adults with moderate to severe atopic dermatitis is currently enrolling by invitation.
-
FDA approval · 2025-09-16FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (RISING PHARMA HOLDINGS, INC.)
FDA approved a supplemental application to add Fluocinolone Acetonide Oil as an approved topical formulation of fluocinolone acetonide by Ri…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
A 10-year registry of children aged 2-17 with eczema who have used pimecrolimus; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China [Phase 4]
A Phase 4 clinical trial evaluating dupilumab in Chinese patients with atopic dermatitis has completed, focusing on skin barrier function an…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis [Phase 3]
Phase 3 trial protocol update for 1% OPA-15406 foam versus vehicle in adult Atopic Dermatitis; not yet recruiting. The study is sponsored by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Dupilumab in Japanese Patients With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial of dupilumab in Japanese patients with atopic dermatitis has completed.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers [NA]
A clinical trial evaluating hypnosis as a management aid for atopic dermatitis in children and teenagers; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating SHR-1819 for efficacy and safety in adults with severe atopic dermatitis is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Staphylococcus Aureus in Atopic Dermatitis Immunopathology [NA]
A completed clinical trial investigating the role of Staphylococcus aureus in the immunopathology of Atopic Dermatitis.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis [Phase 4]
This Phase 4 trial update evaluates using dupilumab with a step-down strategy to maintain remission in adults and adolescents with atopic de…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study
This exploratory clinical trial evaluates the effects of RV4660C CY0203 on clinical, biometric and biological parameters in adults with mild…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 trial is comparing topical crisaborole 2% with tacrolimus 0.1% in children with mild-to-moderate atopic dermatitis. The study stat…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating ICP-332 in moderate to severe atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis [Phase 2]
Phase 2 maximal-use study results for Tapinarof Cream 1% in pediatric patients with extensive atopic dermatitis have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults [Phase 3]
A Phase 3 trial evaluating tapinarof for atopic dermatitis in children and adults has completed with results posted.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks [NA]
An open-label study evaluating tolerance and efficacy of RV4421B in various populations with atopic dermatitis over 12 weeks; the trial stat…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
A registry study in Taiwan is evaluating Abrocitinib for atopic dermatitis, focusing on real-world treatment patterns and outcomes (ATTRACT …
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial results evaluating the efficacy and safety of roflumilast cream in Atopic Dermatitis have been completed.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) [Phase 3]
Organon announced the completion of a Phase 3 trial evaluating tapinarof for atopic dermatitis in children and adults, with results posted o…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients [Phase 1]
This document announces the completion of a first-in-human Phase 1 study of IBI356 in healthy participants and in patients with atopic derma…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD [Phase 3]
Phase 3 trial of 1% OPA-15406 ointment in adults with atopic dermatitis demonstrated superiority to vehicle.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus Placebo
A completed clinical trial evaluating the efficacy of a dermocosmetic product RT00401-GO0046 for reducing atopic dermatitis severity versus …
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
A clinical trial update describing the population with moderate to severe atopic dermatitis treated by systemic therapies and their needs re…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Social Media Follow-up Nursing for Atopic Dermatitis [NA]
Completed clinical trial evaluating social media follow-up nursing for patients with atopic dermatitis.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes [NA]
A clinical trial update evaluating the effectiveness of psychodermatologic educational modules for patients with Atopic Dermatitis, with the…